Atherosclerosis
Volume 194, Issue 2 , Pages 473-482 , October 2007

ApoB-100 carrying lipoprotein, but not apoB-48, is the major subset of proatherogenic remnant-like lipoprotein particles detected in plasma of sudden cardiac death cases

  • Katsuyuki Nakajima

      Affiliations

    • Department of Forensic Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan
    • Corresponding Author InformationCorresponding author at: 3-33-2, Minami-cho, Maebashi, Gunma 371-0805, Japan. Tel.: +81 90 1124 7298; fax: +81 27 243 6390.
    • ,
  • Yasuhiro Nakajima

      Affiliations

    • Department of Forensic Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan
    • ,
  • Sanae Takeichi

      Affiliations

    • Department of Forensic Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan
    • ,
  • Masaki Q. Fujita

      Affiliations

    • Department of Legal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan

Received 30 June 2006 ,Revised 16 August 2006 ,Accepted 22 August 2006.

References 

  1. Twickler TB, Dallinga-Thie GM, Cohn JS, Chapman MJ. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype. Circulation. 2004;109:1918–1925
  2. Nakajima K, Nakano T, Tanaka A. The oxidative modification hypothesis of atherosclerosis: The comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma. Clin Chim Acta. 2006;367:36–47
  3. Sakata K, Miho N, Shirotani M, Yoshida H, Takada A. Remnant-like particles cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery. Atherosclerosis. 1998;136:225–231
  4. Miwa K, Makita T, Ihsii K, Okuda N, Taniguchi A. High remnant lipoprotein levels in patients with variant angina. Clin Cardiol. 2004;27:338–425
  5. Kasteline JJ, Jukema IW, Zwinderman AH, et al. Lipoprotein lipase activity is associated with severity of angina pectoris. Circulation. 2000;102:1629–1633
  6. Igarashi Y, Tamura Y, Suzuki K, et al. Coronary artery spasm is a major cause of sudden cardiac arrest in surviors without underlying heart disease. Coron Artery Dis. 1993;4:177–185
  7. Takeichi S, Nakajima Y, Osawa M, et al. The possible role of remnant-like particles as a risk factor for sudden cardiac death. Int J Legal Med. 1997;110:213–219
  8. Takeichi S, Yukawa N, Nakajima Y, et al. Association of plasma triglyceride-rich lipoprotein remnants with coronary artery atherosclerosis in cases of sudden cardiac death. Atherosclerosis. 1999;142:309–315
  9. Takeichi S, Nakajima Y, Yukawa N, et al. Association of plasma triglyceride-rich lipoprotein remnants with “Pokkuri disease”. Legal Med. 2001;3:84–94
  10. Ohara N, Takeichi S, Naito Y, et al. Remnant-like particles from subjects who died of coronary artery disease suppress NO synthetase activity and attenuate endothelium-dependent vasorelaxation. Clin Chim Acta. 2003;338:151–156
  11. Takeichi S, Nakajima Y, Yukawa N, et al. Validity of plasma remnant lipoproteins as surrogate markers of antemortem level in cases of sudden coronary death. Clin Chim Acta. 2004;343:93–10311
  12. Oi K, Shimokawa H, Hiroki J, et al. Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic avtivity through upregulation of Rho-kinase. Arterioscler Thromb Vasc Biol. 2004;24:918–92211
  13. Nakajima K, Saito T, Tamura A, et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti A-1 immunoaffinity mixed gels. Clin Chim Acta. 1993;223:53–71
  14. Campos E, Nakajima K, Tanaka A, Havel RJ. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res. 1992;33:369–380
  15. Schneeman BO, Kotite L, Todd KM, Havel RJ. Relationships between the responses of triglyceride rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans.. Proc Natl Acad Sci USA. 1993;90:2069–2073
  16. Nakajima K, Okazaki M, Tanaka A. Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apo B-100 and apo-A1. J Clin Ligand Assay. 1996;19:177–183
  17. Marcoux C, Tremblay M, Nakajima K, Davignon J, Cohn JS. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipidemic patients. J Lipid Res. 1999;40:636–647
  18. Kinoshita M, Kojima M, Matsushima T, Teramoto T. Determination of apolipoprotein B-48 in serum by a sandwich ELISA. Clin Chim Acta. 2005;351:115–120
  19. Sakai N, Uchida Y, Ohashi K, et al. Measurement of fasting serum.apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA.. J Lipid Res. 2003;44:1256–1262
  20. Usuki Y, Mokuno H. Characterization of lipoproteins containing apolipoprotein B-100 in remnant-like partcles (RLP) and its association with coronary artery disease (CAD). Juntendoh-Igaku. 2000;46:48–61
  21. Imke C, Rodriguez BL, Grove JS, et al. Are remanat-like particles independent predictors of coronary heart disease incidence? The Honolulu heart study. Arterioscler Thromb Vasc Biol. 2005;25:1718–1722
  22. Ooi TC, Cousins M, Ooi DS, et al. Postprandial remnant- like lipoproteins in hypertriglyceridemia. J Clin Endocrinol Metab. 2001;86:3134–3142
  23. Cohn JS, McNamara JR, Cohn SD, et al. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal.. J. Lipid Res. 1988;29:925–936
  24. Karpe F, Steiner G, Olivecrona T, Carison LA, Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J. Clin. Invest. 1993;91:748–758
  25. Iso H, Naito Y, Sato S, et al. Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol. 2001;153:490–499
  26. Phillips NR, Waters D, Havel R. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation. 1993;88:2762–2770
  27. Okazaki M, Usui S, Tada N, Nakano T, Nakajima K. Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in RLP-cholesterol profiles by HPLC. Clin Chim Acta. 2000;296:135–149
  28. Campos E, Kotite L, Blanche P, et al. Propertis of triglyceride-rich and cholesterol-rich lipoproteins in remnant-like particle fraction of human blood plasma. 2002;43:365–374
  29. Chait A, Mancini M, Feburary AW, et al. Clinical and metabolic study of alcoholic hyperlipidemia. Lancet. 1972;8:62–64
  30. Pownall. Dietary ethanol is associated with reduced lipolysis of intestinally drived lipoproteins. J Lipid Res 1994;35:2105–13.
  31. Castelli WP, Gordon T, Hjortland MG, et al. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study.. Lancet. 1977;2:153–155
  32. Taskinen MR, Nikkila EA. Nocturnal hypertriglyceridemia and hyperinsulinemia following moderate evening intake of alcohol. Acta Med Scand. 1977;202:173–177
  33. Schneider J, Liesenfeld A, Mordasini R, et al. Lipoprotein fractions, lipoprotein lipase and hepatic triglyceride lipase during short-term and long term uptake of ethanol in healthy subjects. Atherosclerosis. 1985;57:281–291

PII: S0021-9150(06)00532-6

doi: 10.1016/j.atherosclerosis.2006.08.057

Atherosclerosis
Volume 194, Issue 2 , Pages 473-482 , October 2007

Article Tools

* Image Usage & Resolution